Showing 2061-2070 of 2727 results for "".
- Global Study Finds Post-COVID Surge in Cosmetic Procedures, Led by Nonsurgical Fat Reductionhttps://modernaesthetics.com/news/global-study-finds-post-covid-surge-in-cosmetic-procedures-led-by-nonsurgical-fat-reduction/2485998/A global analysis of aesthetic procedure trends suggests the COVID-19 pandemic produced both immediate and sustained shifts in cosmetic procedure demand, with notable regional differences in surgical and nonsurgical treatments.
- Study Reports Improved Tolerability with Biomimetic Exosome Retinalhttps://modernaesthetics.com/news/study-reports-improved-tolerability-with-biomimetic-exosome-retinal/2485852/A novel retinal formulation delivered via a biomimetic exosome platform was associated with significant clinical improvements in photodamaged skin without reported irritation, according to a 12-week study published in the Journal of Cosmetic Dermatology. In the single-center study
- Lynch Regenerative Medicine Names General Counsel, CMOhttps://modernaesthetics.com/news/lynch-regenerative-medicine-names-general-counsel-cmo/2485740/Lynch Regenerative Medicine (LRM), a regenerative medicine company focused on platelet-derived growth factor–based therapies, has named Madison Dini as General Counsel and Chad Lindemann as Chief Marketing Officer. According to the company, Dini will lead legal, compliance, and corporate g
- Merz Aesthetics Marks 15 Years of XEOMIN® With New National Campaignhttps://modernaesthetics.com/news/merz-aesthetics-marks-15-years-of-xeomin-with-new-national-campaign/2485650/Merz Aesthetics is commemorating 15 years since the US Food and Drug Administration (FDA) approved XEOMIN® (incobotulinumtoxinA) for aesthetic use, marking a milestone for the company’s flagship neurotoxin in the competitive US injectable market. Approved f
- A Whole-Face, Whole-Patient Framework Review for Aesthetic Consultationhttps://modernaesthetics.com/news/a-whole-face-whole-patient-framework-review-for-aesthetic-consultation/2485626/Aesthetic facial rejuvenation is increasingly defined by comprehensive, patient-centered assessment rather than isolated correction of individual features, according to a multidisciplinary review published in Dermatologic Surgery. Drawing on insights from dermatology, plastic surgery, an
- Aesthetic Sequelae of GLP-1 Receptor Agonists Highlighted in Clinical Reviewhttps://modernaesthetics.com/news/aesthetic-sequelae-of-glp-1-receptor-agonists-highlighted-in-clinical-review/2485615/Dermatologists are increasingly encountering aesthetic complications associated with GLP-1 receptor agonist (RA)–induced weight loss, according to a clinical review presented at the South Beach Symposium. The poster, b
- Prolactin Receptor Blockade May Promote Hair Growth via Follicular Stem Cell Activationhttps://modernaesthetics.com/news/prolactin-receptor-blockade-may-promote-hair-growth-via-follicular-stem-cell-activation/2485612/Blocking prolactin receptor (PRLR) signaling with the investigational antibody ABS-201 promoted hair follicle growth and stem cell activation in human male scalp skin models, according to preclinical data from Jérémy Chéret, PhD, MSc, at the South Beach Symposium
- New Consensus Algorithm Guides Skincare Use With Energy-Based Acne Treatmentshttps://modernaesthetics.com/news/new-consensus-algorithm-guides-skincare-use-with-energy-based-acne-treatments/2485595/A new consensus-based study published in Journal of Drugs in Dermatology outlines a practical, stepwise algorithm for integrating skincare with energy-based devices (EBDs) in the management of acne and acne sequelae. Titled “Practical Algorithm for Acne Treatment Integrating Skincare
- New JDD Study Explores Aesthetic Motivations of African American Womenhttps://modernaesthetics.com/news/new-jdd-study-explores-aesthetic-motivations-of-african-american-women/2485593/A new survey-based study published in Journal of Drugs in Dermatology examines the cosmetic concerns, motivations, and skincare behaviors that shape the aesthetic journey of African American (AA) women, highlighting hair loss and hyperpigmentation as leading priorities in this population
- IMCAS 2026: Galderma Survey Sheds Light on Menopause and Skin Healthhttps://modernaesthetics.com/news/imcas-2026-galderma-survey-sheds-light-on-menopause-and-skin-health/2485587/Galderma presented findings from a large global survey examining the dermatologic impact of menopause at the International Master Course on Aging Science (IMCAS) 2026 World Congress, held January 29–31 in Paris, France. The survey notes persistent gaps in awareness and education around menopause-